Background illustration for clinical trials search

Pancreatic Cancer Clinical Trials

Browse 1,722 pancreatic cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care

for
Colorectal Cancer, Pancreatic Cancer
Location: Lexington KY
Sponsor: Reema A. Patel

Sex: All

Age: 18+

Code: NCT05391126

Recruiting

Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients

for
Colorectal Cancer, Esophageal Cancer, Gastric Cancer,
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 18+

Code: NCT00899626

Recruiting

Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury

for
Lung Cancer, Radiation Fibrosis, Radiation Induced Lung Injury,
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18 - 70+

Code: NCT04485286

Phase 2, Recruiting

Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer

for
Pancreatic Cancer
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT06423963

Recruiting

Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma

for
Thymoma, Stomach Neoplasms, Pancreatic Neoplasms, Mesothelioma,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 2 - 70+

Code: NCT01950572

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

for
Ovarian Neoplasms, Endometrial Neoplasms,
Location: Mineola NY, New York NY, Columbus OH, Atlanta GA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06400472

Phase 1, Recruiting

Resilience and Equity in Aging, Cancer, and Health (REACH)

for
Gastric Cancer, Colon Cancer, Esophageal Cancer, Rectal Cancer,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 65+

Code: NCT04674267

Recruiting

EUS-CPN With and Without Bupivacaine

for
Pancreatic Cancer
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18+

Code: NCT04951804

Recruiting

DCE-MRI Guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer

for
Borderline-resectable Pancreatic Cancer
Location: Columbus OH, Indianapolis IN
Sponsor: Ohio State University

Sex: All

Age: 19+

Code: NCT06173310

Recruiting

Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer

for
Pancreas Cancer
Location: Edmonton, Calgary
Sponsor: AHS Cancer Control Alberta

Sex: All

Age: 18+

Code: NCT01411072

Recruiting

Familial Investigations of Childhood Cancer Predisposition

for
Acute Leukemia, Adenomatous Polyposis, Adrenocortical Carcinoma,
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0+

Code: NCT03050268

Recruiting

Pancreatic Cancer Genetics

for
Pancreatic Cancer
Location: New York NY
Sponsor: Columbia University

Sex: All

Age: 18 - 70+

Code: NCT01102569

Recruiting

A Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic Cancer

for
Pancreatic Cancer
Location: Montreal
Sponsor: Petr Kavan

Sex: All

Age: 18+

Code: NCT03167112

Phase 2, Recruiting

Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy

for
Duodenal Neoplasm, Pancreatic Neoplasm
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 18+

Code: NCT06411795

Phase 2, Recruiting

High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies

for
Liver Malignant Tumors, Cholangiocarcinoma Metastatic,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 19+

Code: NCT05053555

Recruiting

Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors

for
VHL Pancreatic Neuroendocrine Tumors, Von Hippel-Lindau Disease,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12+

Code: NCT04074135

Phase 2, Recruiting

Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer

for
Pancreatic Cancer
Location: Boston MA, Hartford CT, Charlottesville VA, Houston TX,
Sponsor: Craig L Slingluff, Jr

Sex: All

Age: 18+

Code: NCT02305186

Phase 1, Phase 2, Recruiting

Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation Program

for
Pancreatic Cancer, Liver Cancer, Bile Duct Cancer,
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

Sex: All

Age: 18 - 70+

Code: NCT03475966

Recruiting

Coordinating and Data Management Center for the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer

for
Chronic Pancreatitis, Diabetes, Pancreatic Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT03058926

Recruiting

Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer

for
Pancreas Cancer, Pancreatic Cancer
Location: Charlottesville VA
Sponsor: University of Virginia

Sex: All

Age: 18+

Code: NCT06479239

Phase 1, Phase 2, Recruiting

What is pancreatic cancer?

The pancreas sits deep behind the stomach and makes both digestive enzymes and hormones like insulin. About 92 percent of pancreatic cancers start in the enzyme making cells, and this page is mostly about those. The other 8 percent are neuroendocrine tumors, which grow more slowly, have their own trials, and a five year survival of 72 percent against 8 percent. The pancreas gives no early warning. Jaundice, back pain, weight loss and new diabetes usually appear only after the cancer has grown or spread, and fewer than 20 percent of people can have surgery at diagnosis.

Smoking roughly doubles the risk, and type 2 diabetes, extra weight, chronic pancreatitis and family history raise it. About 10 percent of cases come from inherited mutations, so guidelines now recommend genetic testing for everyone diagnosed. That can change treatment and flag relatives who should be watched. The hope comes from biology. More than 90 percent of pancreatic cancers carry a KRAS mutation. That target was called undruggable for decades. Now several RAS inhibitors are in trials, with the first Phase 3 studies recruiting. Pancreatic cancer shares risk factors with type 2 diabetes and inherited genes with breast and ovarian cancer.

Article preview image

Our guide to new treatments for pancreatic cancer covers what has been approved and what is being tested.

Research Paving The Way To A New Treatment For Pancreatic Cancer

Types of pancreatic cancer clinical trials

Who can participate in pancreatic cancer clinical trials?

What causes pancreatic cancer?

The stages of pancreatic cancer, and why they matter for trials

How to enroll in a pancreatic cancer clinical trial